- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Petros Grivas, MD, PhD | Authors
Articles
Petros Grivas, MD, PhD, on the Implications of the COVID-19 and Cancer Consortium
July 19, 2020
The expert oncologist spoke about the conclusions drawn from the COVID-19 and Cancer Consortium, as well as the importance of prognostic biomarkers.
Petros Grivas, MD, PhD, on Future Updates to the COVID-19 and Cancer Consortium
July 09, 2020
Data from the registry suggested that in patients with cancer and COVID-19, cancer that is progressing was independently associated with an increased risk of death.
Petros Grivas, MD, PhD, on Advice for Patients with Cancer During the COVID-19 Pandemic
July 05, 2020
The expert oncologist discussed the findings of the COVID-19 and Cancer Consortium and how the results of the consortium should inform conversations with patients with cancer.
Petros Grivas, MD, PhD, on the Future of the CCC19 Registry
May 29, 2020
Data from the COVID-19 and Cancer Consortium registry, presented at the 2020 ASCO Annual Virtual Science Program, reported how the COVID-19 pandemic has impacted patients with cancer thus far.
Emerging Immunotherapy Approaches For Urothelial Cancer
February 04, 2019
Cancer Network spoke with Dr. Petros Grivas about emerging immunotherapy approaches for the treatment of advanced urothelial cancer.
Considering Neoadjuvant Chemotherapy Options in Bladder Cancer
June 17, 2016
In this peer-to-peer discussion Dr. Grivas and Dr. Palmbos examine the role of neoadjuvant chemotherapy in bladder cancer and weigh the various trial data guiding these treatment decisions.